Volume 27, Number 4—April 2021
Synopsis
Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses
Table 1
Pathogen (abbreviation) | Disease (abbreviation) | Viral genus | Receptor (abbreviation) [suspected] |
---|---|---|---|
Alphacoronavirus 1 (ACoV1); strain canine enteric coronavirus (CCoV) | Canine coronavirus infection (CCoV) | Alphacoronavirus | Aminopeptidase N (APN, CD13) |
Alphacoronavirus 1 (ACoV1); strain feline infectious peritonitis virus (FIPV) | Feline infectious peritonitis virus (FIP) | Alphacoronavirus | Aminopeptidase N (APN, CD13) |
Bat coronavirus HKU10 | NA | Alphacoronavirus | Unknown |
Ferret systemic coronavirus (FRSCV) | Ferret systemic coronavirus (FRSCV)–associated disease | Alphacoronavirus | Unknown |
Human coronavirus NL63 | Common cold | Alphacoronavirus | Angiotensin-converting enzyme 2 (ACE2) |
Human coronavirus 229E | Common cold | Alphacoronavirus | Human aminopeptidase N (hAPN, CD13) |
Porcine epidemic diarrhea virus (PEDV) | Porcine epidemic diarrhea (PED) | Alphacoronavirus | [Aminopeptidase N (APN, CD13)] |
Rhinolophus bat coronavirus HKU2; strain swine acute diarrhea syndrome coronavirus (SADS-CoV) | Swine acute diarrhea syndrome (SADS) | Alphacoronavirus | Unknown |
Betacoronavirus 1; strain bovine coronavirus | NA | Betacoronavirus | Human leukocyte antigen class I (HLA-1) |
Betacoronavirus 1; strain canine respiratory coronavirus | Canine infectious respiratory disease (CIRD) | Betacoronavirus | Human leukocyte antigen class I (HLA-1) |
Betacoronavirus1; strain human coronavirus OC43 | Common cold | Betacoronavirus | Human leukocyte antigen class I (HLA-1) |
Human coronavirus HKU1 | Common cold | Betacoronavirus | Human leukocyte antigen class I (HLA-1) |
Middle East respiratory syndrome coronavirus (MERS-CoV) | Middle East respiratory syndrome (MERS) | Betacoronavirus | Dipeptidyl peptidase 4 (DPP4, CD26) |
Severe acute respiratory syndrome coronavirus (SARS-CoV) | Severe acute respiratory syndrome (SARS) | Betacoronavirus | Angiotensin-converting enzyme 2 (ACE2) |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | Coronavirus disease (COVID-19) | Betacoronavirus | Angiotensin-converting enzyme 2 (ACE2) |
Page created: January 25, 2021
Page updated: March 18, 2021
Page reviewed: March 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.